Special Radiation Techniques in Sarcoma Management

There are many ongoing advances in the context of radiation therapy delivery for patients with primary soft tissue sarcoma of the extremity/trunk with emerging practice-changing clinical research and new treatment options, some of which are not yet standard of care. Failure to stay informed leads to lower quality of care by practicing clinicians. 
This webinar presents new approaches in management of sarcoma using radiation therapy, including novel fractionation schedules, hypofractionation, novel dose strategies and novel combinations with systemic therapy. 

Target Audience

This activity is designed to meet the interests of radiation oncologists, medical oncologists, physicists, radiation biologists, dosimetrists, radiation therapists, surgeons and residents. 

Learning Objectives

Upon completion of this activity, participants should be able to do the following: 

  • Understand standard versus non-standard radiation treatments for primary extremity/trunk sarcoma.
  • Understand emerging hypofractionation treatments for primary extremity/trunk sarcoma.
  • Utilize emerging radiation and immunotherapy combinations for primary extremity/trunk sarcoma.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
06/04/2025
Course expires: 
07/05/2027
Cost:
$0.00
Part of: 
Advances in Sarcoma Treatment Webinar Series
Rating: 
0
  • Anusha Kalbasi, MD, is employed by Stanford University. Dr. Kalbasi owns stock in Certis Oncology; receives compensation/payment from T Cure Therapeutics; and receives grant/research funding from Highlight Therapeutics.
  • Meng Welliver, MD, PhD, is employed by Mayo Clinic Alix School of Medicine.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians. 

Available Credit

1.00 Certificate of Attendance

This activity was designated for 1.00 AMA PRA Category 1 credit.™ 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.